Department of Internal Medicine, Pusan National University School of Medicine, and Biomedical Research Institute, Pusan National University Hospital, 179, Gudeok-ro, Seo-Gu, Busan, 49241, Republic of Korea.
Department of Internal Medicine, Joeun Gumgang Hospital, 1814-37 Gimhae-daero, Gimhae-si, Gyeongsangnam-do, Republic of Korea.
Surg Endosc. 2018 Apr;32(4):1963-1970. doi: 10.1007/s00464-017-5892-3. Epub 2017 Oct 18.
Application of endoscopic submucosal dissection (ESD) for undifferentiated-type early gastric cancers (EGCs) remains controversial owing to limited data regarding long-term outcomes. We aimed to evaluate the feasibility of ESD for undifferentiated-type EGCs that meet the expanded criteria (EC).
We performed a retrospective analysis of 66 patients who underwent ESD for undifferentiated-type EGC between January 2005 and December 2014. We evaluated the rates of en bloc, complete, and curative resections along with overall survival (OS), disease-specific survival (DSS), and recurrence-free survival (RFS).
Of the 66 patients, the EC group included 38 patients and the beyond-EC group included 28 patients. The overall rates of en bloc, complete, and curative resection of the 66 lesions were 92.4% (61/66), 65.2% (43/66), and 48.5% (32/66), respectively. Of the 34 patients with non-curative resection, 18 underwent additional surgery. Local remnant cancer was detected in 1 patient (1/18, 5.6%), and none of the 18 patients had lymph node metastasis. On multivariate analysis, tumors > 2 cm [odd ratio (OR) 6.183, 95% confidence interval (CI) 1.279-29.880, p = 0.023) and submucosal invasion depth (OR 6.226, 95% CI 1.881-20.606, p = 0.003) were independent predictors of incomplete resection. All 26 patients with more than 1 year of follow-up after curative resection survived without any evidence of local or distant recurrences over a median follow-up period of 36 months. The OS, DSS, and RFS rates of patients with curative ESD were 93.8, 100, and 100%, respectively.
ESD may have favorable long-term outcomes in patients with undifferentiated-type EGC after curative resection.
内镜黏膜下剥离术(ESD)应用于未分化型早期胃癌(EGC)仍存在争议,因为关于长期结果的数据有限。我们旨在评估符合扩大标准(EC)的未分化型 EGC 行 ESD 的可行性。
我们对 2005 年 1 月至 2014 年 12 月期间行 ESD 治疗的 66 例未分化型 EGC 患者进行了回顾性分析。我们评估了整块、完全和治愈性切除的比率以及总生存率(OS)、疾病特异性生存率(DSS)和无复发生存率(RFS)。
在 66 例患者中,EC 组 38 例,超出 EC 组 28 例。66 个病灶的整块、完全和治愈性切除的总体比率分别为 92.4%(61/66)、65.2%(43/66)和 48.5%(32/66)。在 34 例非治愈性切除的患者中,18 例患者接受了额外的手术。1 例(1/18,5.6%)患者局部残胃癌,18 例患者均无淋巴结转移。多因素分析显示,肿瘤>2cm(比值比(OR)6.183,95%置信区间(CI)1.279-29.880,p=0.023)和黏膜下浸润深度(OR 6.226,95%CI 1.881-20.606,p=0.003)是不完全切除的独立预测因素。所有 26 例治愈性 ESD 后随访时间超过 1 年的患者在中位随访 36 个月期间均无局部或远处复发,存活且无任何证据。治愈性 ESD 患者的 OS、DSS 和 RFS 率分别为 93.8%、100%和 100%。
在治愈性切除后,ESD 可能对未分化型 EGC 患者有良好的长期结果。